Drug Patent Expirations in September 2009

The following drugs face patent expirations in September 2009

Applicant :: TRADENAME :: generic name

Merck :: PRIMAXIN :: cilastatin sodium; imipenem
Novartis :: NEORAL :: cyclosporine
Alcon :: TOBRADEX :: dexamethasone; tobramycin
Alcon :: TOBRADEX ST :: dexamethasone; tobramycin
Organon Usa Inc :: IMPLANON :: etonogestrel
Meda Pharms :: FELBATOL :: felbamate
Alcon :: TOBRASONE :: fluorometholone acetate; tobramycin
Pfizer :: GLUCOTROL XL :: glipizide
Pharmacia And Upjohn :: XALATAN :: latanoprost
Novartis :: STARLIX :: nateglinide
Gtx Inc :: FARESTON :: toremifene citrate

This list does not discriminate between dominant and non-dominant patents. Listed drugs above may be protected by additional patents and other regulatory protections.

For more details, visit DrugPatentWatch at http://www.DrugPatentWatch.com 

To subscribe to the free Patent Expiration Bulletin, visit http://www.DrugPatentWatch.com/newsletter 

Disclaimer:
All trademarks and applicant names are the property of their respective owners or licensors. Drug patent expiration data is presented "as is." Use of this information is at your own risk. No warranty is expressed or implied. There is no warranty that the drug patent expriation information is error free.

---
ABOUT DrugPatentWatch ( http://www.DrugPatentWatch.com  )

DrugPatentWatch provides information on drug patent expirations. Complete details are provided for all FDA-approved small molecule drugs. Sales information is available for top-selling drugs. This value-added information supports the critical business functions of patent agents and attorneys, pharmaceutical companies, wholesalers, healthcare payers, and investors.